Scrabble pieces spelling out kidney cancer

Researchers pinpoint a protein that may predict untreatable kidney cancer

June 4, 2020

A team of researchers confirmed the role of a certain protein in the development of high-grade kidney cancer. The researchers also showed that a higher level of the protein can be used as a marker to predict which tumors will develop treatment resistance and progress more rapidly.

Risk of death twice as high among cancer patients with COVID-19

May 29, 2020

Mays Cancer Center faculty members authored the data analysis involving more than 900 cancer patients.


Cancer drugs cause large cells that resist treatment; scientist aims to stop it

May 28, 2020

Fueled by genetic changes due to cancer therapy itself, rogue cells may become very large with twice or quadruple the number of chromosomes found in healthy cells. Dr. Daruka Mahadevan, of the Mays Cancer Center, seeks to find drugs that prevent or treat this problem.

Close up of medical drip or IV drip chamber in patient room.

Results published of remdesivir, COVID-19 trial

May 28, 2020

According to the study, the drug improved recovery time and decreased the number of deaths.

Faculty present their innovations at virtual pitch day

May 22, 2020

Nine UT Health San Antonio clinicians and scientists pitched their innovations in the President’s Translational and Entrepreneurial Research Fund (PTEF) virtual forum held May 20.

Close up of medical drip or IV drip chamber in patient room.

Second phase of clinical trial for promising COVID-19 drug begins

May 15, 2020

Second phase includes FDA-approved anti-inflammatory drug along with remdesivir.